98%
921
2 minutes
20
Membrane-active peptides (MAPs) exhibit great potential in biomedical applications due to their unique ability to overcome the cell membrane barrier. However, the interactions between MAPs and membranes are complex, and little is known about the possibility of MAP action being specific to certain types of membranes. In this study, a combination of molecular dynamics simulations and theoretical analysis was utilized to investigate the interactions between typical MAPs and realistic cell membrane systems. Remarkably, the simulations revealed that MAPs can attack membranes by generating and sensing positive mean curvature, which is dependent on lipid composition. Furthermore, theoretical calculations demonstrated that this lipid-regulated curvature-based membrane attack mechanism is an integrated result of multiple effects, including peptide-induced membrane wedge and softening effects, the lipid shape effect, the area-difference elastic effect, and the boundary edge effect of formed peptide-lipid nanodomains. This study enhances our comprehension of MAP-membrane interactions and highlights the potential for developing membrane-specific MAP-based agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.jpclett.3c01115 | DOI Listing |
Proc Natl Acad Sci U S A
September 2025
Laboratory of Computational Biology, National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Membrane active peptides (MAPs) represent a diverse group of agents that disrupt the integrity of lipid membranes. One class of MAPs, antimicrobial peptides (AMPs), destroy bacteria by transiently porating the bacterial membrane causing leakage of cellular contents. Transient leakage is classified as "graded," where all vesicles in a population leak partially, or "all-or-none," where some vesicles leak completely.
View Article and Find Full Text PDFACS Appl Mater Interfaces
August 2025
Department of Chemical and Biological Science and Engineering, United States Military Academy, West Point, New York 10996, United States.
Pore-forming agents can bind at the interface of and permeabilize cell membranes. Understanding and mitigating this mechanism is pragmatic for developing bionanomaterials and strategies against biologically active species that target the cell membrane. Herein, we explore the molecular interactions between melittin, a membrane-active pore-forming peptide from honeybee venom, and a series of structurally similar polyphenols.
View Article and Find Full Text PDFBiochim Biophys Acta Biomembr
August 2025
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St., Moscow 117997, Russian Federation; Research Institute for Systems Biology and Medicine, 18 Nauchny Proezd St., Moscow 117246, Russian Federation; National Research University Higher Scho
The coronavirus spike protein, the key entity effectuating membrane fusion, cannot exist without membrane-active fragments. In addition to fusion peptides, among such domains are HR1 and HR2. Crucial to the spike's refolding and membrane fusion, they are believed to both interact with each other and bind to the membranes that are merged.
View Article and Find Full Text PDFJ Med Chem
August 2025
Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
Antimicrobial peptides (AMPs) are promising alternatives to traditional antibiotics. This study uses alchemical free energy simulations to design ultrashort, cationic, broad-spectrum membrane-active peptides. Previously, we identified broad-spectrum peptide P4 (LKWLKKL-NH, charge +4) with moderate activity (10-50 μM) but it was ineffective against Methicillin-resistant (MRSA).
View Article and Find Full Text PDFJ Mater Chem B
August 2025
Laboratory of Molecular Materials, Division of Biophysics and Bioengineering, Linköping University, 581 83 Linköping, Sweden.
Liposomes are widely utilized in drug delivery systems to enhance pharmacokinetics and reduce side effects. Bioresponsive membrane-active peptides (MAPs) can modulate the release of encapsulated drugs from liposomes, improving therapeutic efficacy. However, achieving efficient and specific conjugation of MAPs to liposomes remains challenging, complicating translational efforts.
View Article and Find Full Text PDF